In order to prioritize patients first in a multitrillion-dollar industry, health care innovators and leaders must strive to deliver the same kind of consumer-centric experience the retail, real estate, utilities and travel sectors, among others, have successfully achieved, without leaving patients feeling as if they are nothing more than a seven-digit identification number. Particularly in this era of efficiency-driven innovation and technology, the tools that can eliminate agonizing wait times, bypass the bureaucratic specialist referral process and simplify everything from paperwork to appointment setting will get the industry off to a good start in the race to transform an ailing health care system. Offering a promising cure that not only puts consumers at the center of the health care experience but also enables doctors to practice to their highest potential, technology holds the key in returning the U.S. to its rightful place as a pioneer in advancing the health and wellness of every individual on the planet.


About the Author: Robert E. Grant is founder and chief executive officer of CONCIERGE KEY Health, the first mobile app that provides on-demand access to elite doctors, urgent care clinics and hospitals nationwide. An entrepreneur, inventor and investor, he has played a pivotal role for more than 20 years in successful technology and business development in pharmaceutical, medical device and health care markets. In addition to founding CONCIERGE KEY, Grant is founder and vice chairman of ALPHAEON Corporation, as well as founder, chairman and managing partner of its parent company, Strathspey Crown Holdings LLC. Most recently, Grant was CEO and president of Bausch+Lomb Surgical, leading the significant growth of its product portfolio. From 2006 to 2010, he served as president of Allergan Medical, leading the $3.2 billion Inamed acquisition and the commercial success of the Botox Cosmetic, Juvederm, Natrelle breast implants and Lap-Band brands. Grant also served as director, board chairman, CEO, president, COO and CFO of Biolase Technology from 2003 to 2006 after holding various senior management positions at Lumenis for six years.


Back to HCB News

Health IT Homepage